Company: AIP
Filing Date: 2025-02-18
Form Type: 10-K
Source: 0001667011-25-000010
Chunk: 2

Company: Arteris, Inc.
Filing Date: 2025-02-18
Form: 10-K
Item: Item 8
Chunk 2
---
7,631 8,810 Other liabilities1,641 2,412 Total liabilities107,323 87,698 Commitments and contingencies (Note 11)Stockholders’ (deficit) equity:Preferred stock, par value of $0.001—10,000,000 shares authorized and no shares issued and outstanding as of both December 31, 2024, and 2023— — Common stock, par value of $0.001—300,000,000 shares authorized at December 31, 2024, and 2023; 40,724,936 and 37,518,583 shares issued and outstanding at December 31, 2024, and 2023, respectively40 37 Additional paid-in capital135,522 118,193 Accumulated other comprehensive income135 120 Accumulated deficit(136,885)(103,247)Total stockholders’ (deficit) equity(1,188)15,103 TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$106,135 $102,801 

See notes to consolidated financial statements

76

Arteris, Inc.

Consolidated Statements of Operations

(In thousands, except share and per share data)

Year ended December 31,20242023RevenueLicensing, support and maintenance$52,815 $48,273 Variable royalties and other4,909 5,393 Total revenue57,724 53,666 Cost of revenue5,962 5,077 Gross profit51,762 48,589 Operating expenses:Research and development45,007 45,128 Sales and marketing20,796 20,659 General and administrative17,555 17,944 Total operating expenses83,358 83,731 Loss from operations(31,596)(35,142)Interest expense(244)(211)Other income (expense), net3,400 3,558 Loss before income taxes and loss from equity method investment(28,440)(31,795)Loss from equity method investment, net of tax2,698 3,397 Provision for income taxes2,500 1,677 Net loss$(33,638)$(36,869)Net loss per share attributable to common stockholders, basic and diluted$(0.86)$(1.03)Weighted average shares used in computing per share